Medical Therapy. Efficacy or Lack of Efficacy

Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo

Takeshi Furukawa, Masahiko Kishiro, Hideo Fukunaga, Masahiro Ohtsuki, Ken Takahashi, Katsumi Akimoto, Toshiaki Shimizu, Shiori Kawasaki, Toshio KumasakaJuntendo University School of Medicine.Japan Pediatric CardiologyPediatr Cardiol 2010; 31: 773-779DOI: 10.1007/s00246-010-9695-8 AbstractThe outcome of stent implantation for pulmonary vein stenosis (PVS) in children remains poor. Several reports describe placing drug-eluting stents to treat PVS, but their effectiveness remains […]

Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo Read More »

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

Goetz Christoph Mueller, Ali Dodge-Khatami, Jochen WeilUniversity Heart Center Hamburg.Germany Cardiology in the YoungCardiol Young 2010; 20: 455-458DOI: 10.1017/S1047951110000703 AbstractPaclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate Read More »

Losartan ameliorates “upstream” pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis

Jiaquan Zhu, HarukiIde, Yaqin Yana Fu, Anouk-Martine Teichert, Hideyuki Kato, Richard D. Weisel, Jason T. Maynes, John G. Coles, Christopher A. CaldaroneThe Hospital for Sick Children and University of Toronto. Toronto General Hospital. Canada Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 2014; 148: 2550-2557DOI: 10.1016/j.jtcvs.2014.07.050 AbstractObjectives: Pulmonary vein stenosis (PVS) is a relentless disease with

Losartan ameliorates “upstream” pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis Read More »

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK

Anne Hilgendorff, Christian Apitz, Damien Bonnet, Georg HansmannDr von Haunersche Children’s Hospital. Children’s Hospital, University of Ulm. Hôpital Necker Enfants Malades, APHP, Université Paris Descartes. Hannover Medical School. Germany and France HeartHeart 2016; 102 Suppl 2: ii49-56DOI: 10.1136/heartjnl-2015-308591 AbstractPersistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly reversible after a few days

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK Read More »

[Diffuse pulmonary lymphangiomatosis with pleural and pericardial involvement. Pediatric case report]

Rodolfo P. Moreno, Yanina Hernández, Patricia Garrido, Bethy Camargo Vargas, Alberto Hernández, Javier Faín, Cecilia Seligra, Patricia Topp, Alberto Maffey, Gustavo CardigniSanatorio de la Trinidad Palermo. Argintina Archives of Argentina PediatricsArch Argent Pediatr 2021; 119: e264-e268DOI: 10.5546/aap.2021.e264 AbstractDiffuse pulmonary lymphangiomatosis is a rare disease characterized by marked proliferation and dilation of lymphatic vessels in the lungs,

[Diffuse pulmonary lymphangiomatosis with pleural and pericardial involvement. Pediatric case report] Read More »

Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate

Satoshi Tamaoka, Asami Osada, Takane Kin, Takeshi Arimitsu, Mariko HidaKeio University School of Medicine.Japan ChestChest 2021; 159: e189-e191DOI: 10.1016/j.chest.2020.10.071 AbstractA trisomy 21 neonate presented with congenital chylous pleural effusion and ascites that was refractory to conventional pharmacotherapy. Midodrine, an oral alpha-1-adrenoreceptor agonist, achieved remission of chylous effusion without any adverse effects. To the best of our

Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate Read More »

Non-immune hydrops fetalis secondary to congenital chylothorax with diffuse interstitial lung disease: a diagnostic conundrum

Alvin Jia Hao Ngeow, Mei Yoke Chan, Oon Hoe Teoh, Sarat Kumar Sanamandra, Daisy Kwai Lin ChanSingapore General Hospital. KK Women’s and Children’s Hospital. Singapore British Medical Journals Case ReportsBMJ Case Rep 2021; 14: DOI: 10.1136/bcr-2020-240688 AbstractA Chinese male infant was born at 35 weeks weighing 2935 g to a mother with polyhydramnios and prenatal hydrops

Non-immune hydrops fetalis secondary to congenital chylothorax with diffuse interstitial lung disease: a diagnostic conundrum Read More »

Two Cases of Congenital Chylethorax: A Successful Story of Medical Management

I. Kankananarachchi, K. K. S. Priyankara, K. K. K. Lakman, K. Withanaarachchi, P. K. G. GunathilakaUniversity of Ruhuna. Teaching Hospital Karapitiya. Sri Lanka Case Reports in PediatricsCase Rep Pediatr 2021; DOI: 10.1155/2021/6634326 AbstractCongenital chylothorax (CC) is one of the most common causes of pleural effusions in neonates. Associated ipsilateral pulmonary aplasia in CC results in neonatal

Two Cases of Congenital Chylethorax: A Successful Story of Medical Management Read More »

A case of refractory chylothorax treated with Eppikajutsuto

Juma Obayashi, Shigeyuki Furuta, Yukitsugu Nakamura, Kunihide Tanaka, Hiroaki KitagawaSt. Marianna University School of Medicine. Japan Pediatrics InternationalPediatr Int 2022; 64: DOI: 10.1111/ped.14707 AbstractNo Abstract Available CategoryPulmonary Lymphatic DiseaseMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article Access Free

A case of refractory chylothorax treated with Eppikajutsuto Read More »

Staged Management of Congenital Chylothorax With Hydrops Fetalis: An Insight Into EXIT Related Procedures

Hung-Lin Tai, Tze Yee Diane Mok, An-Shine Chao, Shih-Ming Chu, Reyin LienSaint Paul’s Hospital. Chang Gung Memorial Hospital. New Taipei Municipal TuCheng Hospital. Chang Gung Medical Center and Chang Gung University.Taiwan Frontiers in PediatricsFront Pediatr 2021; DOI: 10.3389/fped.2021.633051 AbstractBackground: Idiopathic congenital chylothorax is a rare but serious disease. Advancement in perinatal care and the renovated treatment modalities

Staged Management of Congenital Chylothorax With Hydrops Fetalis: An Insight Into EXIT Related Procedures Read More »

Scroll to Top